FREDERICK W DRISCOLL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDERICK W DRISCOLL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDERICK W DRISCOLL. FREDERICK W DRISCOLL is a Director in OXIGENE INC ($OXGN) and a President and CEO in OXIGENE INC ($OXGN) and a Director in MEI Pharma, Inc. ($MEIP) and a Director in Cellectar Biosciences, Inc. ($CLRB) and a Director in NantKwest, Inc. ($NK) and a Chief Financial Officer in Flexion Therapeutics Inc ($FLXN) and a Director in Cue Biopharma, Inc. ($CUE).
Address: C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM 02451 MA
Companies in which FREDERICK W DRISCOLL is an Insider
Cellectar Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDERICK W DRISCOLL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2020
$CLRB Market Capitalization: $9.82M
$CLRB Previous Close: $1.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cue Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDERICK W DRISCOLL: Director
Holdings: 0 shares
Latest Transaction: Jan 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Flexion Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDERICK W DRISCOLL: Chief Financial Officer
Holdings: 10,777 shares
Current Value: $205,194
Latest Transaction: Mar 24 2017
$FLXN Market Capitalization: $504.85M
$FLXN Previous Close: $19.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunityBio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FREDERICK W DRISCOLL: Director
Holdings: 124,535 shares
Current Value: $636,374
Latest Transaction: Aug 13 2020
$NK Market Capitalization: $425.06M
$NK Previous Close: $5.11
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEI Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDERICK W DRISCOLL: Director
Holdings: 37,500 shares
Current Value: $58,125
Latest Transaction: Feb 24 2021
$MEIP Market Capitalization: $57.00M
$MEIP Previous Close: $1.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncotelic Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDERICK W DRISCOLL: Director, President and CEO
Holdings: 122,000 shares
Latest Transaction: Jun 03 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of FREDERICK W DRISCOLL
Sentiment: All, CLRB, CUE, FLXN, NK, MEIP, MATN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 4.03 | 25,000 | 100,625 | 37,500 | 62.5 K to 37.5 K (-40.00 %) |
| Jan 06 2021 | CUE | Cue Biopharma, Inc ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 12.36 | 10,000 | 123,600 | 10,000 | |
| Aug 13 2020 | NK | NantKwest, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 10.77 | 5,300 | 57,065 | 109,235 | 114.5 K to 109.2 K (-4.63 %) |
| Aug 13 2020 | NK | NantKwest, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 9.98 | 10,000 | 99,787 | 114,535 | 124.5 K to 114.5 K (-8.03 %) |
| Aug 13 2020 | NK | NantKwest, Inc. | DRISCOLL FREDERICK W | Director | Sell | S | 10.22 | 50,000 | 511,200 | 124,535 | 174.5 K to 124.5 K (-28.65 %) |
| Jul 07 2020 | MEIP | MEI Pharma, Inc. | DRISCOLL FREDERICK W | Director | Option Exercise | A | 3.49 | 50,000 | 174,500 | 50,000 | |
| Jun 25 2020 | CLRB | Cellectar Bioscien ... | DRISCOLL FREDERICK W | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 |